| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,7800 | +3,97% | $1,74B | $648,16K | |
SGRY Surgery Partners, Inc. Common Stock | $13,6750 | +1,22% | $1,74B | $1,54M | |
GAB The Gabelli Equity Trust Inc. | $5,6000 | -0,18% | $1,74B | $1,27M | |
HURN Huron Consulting Group Inc. | $107,28 | +2,36% | $1,74B | $133,31K | |
ENVX Enovix Corporation Common Stock | $8,3600 | +1,58% | $1,74B | $7,25M | |
PAYO Payoneer Global Inc. Common Stock | $5,1300 | +0,79% | $1,74B | $6,51M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9300 | +0,13% | $1,73B | $174,04K | |
STGW Stagwell Inc. Class A Common Stock | $6,6900 | +1,52% | $1,73B | $964,68K | |
CASH Pathward Financial, Inc. Common Stock | $79,0350 | +1,67% | $1,73B | $296,81K | |
SNDX Syndax Pharmaceuticals, Inc. | $18,0200 | -1,74% | $1,73B | $7,79M | |
STRA Strategic Education, Inc. Common Stock | $80,4500 | +1,77% | $1,73B | $223,18K | |
CAPR Capricor Therapeutics Inc | $27,9200 | +1,01% | $1,73B | $584,21K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17,8250 | -0,25% | $1,73B | $4,88K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9,0400 | +10,38% | $1,73B | $8,41M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $26,9250 | +7,74% | $1,73B | $640,65K | |
